Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis | RMD Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Early arthritis

Original article

Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Hitchon CA, Meng X, El Gabalawy HS, et al

Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis

RMD Open 2019;5:e000874. doi: 10.1136/rmdopen-2018-000874